Additional file 2.
Table S1. AUC values for 42 breast cancer cell lines treated by TFEC. Table S2. Clinical and demographic characteristics of breast cancer patients in this study compared with patients in USO trial. Table S3. Two hundred and ninety one affymetrix probes used in TFEC-MGP. The gene symbols and descriptions of these probes were obtained by using broad institute’s molecular signatures database v3.0 (http://www.broadinstitute.org/gsea/msigdb/index.jsp webcite). Table S4. Identified enriched pathways.
Format: DOCX Size: 59KB Download file
Shen et al. BMC Medical Genomics 2012 5:51 doi:10.1186/1755-8794-5-51